Federal Court Overturns Gilead Sciences and Merck Patent Dispute Post author:Sam Post published:February 19, 2018 Post category:BioPharma Federal court judge orders Merck to repay $2.5 Billion to Gilead in overturned patent decision. Source: BioSpace You Might Also Like Agilent Enhances Exome Sequencing For Clinical Research March 20, 2017 Novelion to Cut an Unknown Number of Jobs in Restructuring January 25, 2018 Hill-Rom To Host Fiscal Fourth Quarter 2017 Earnings Conference Call And Webcast September 28, 2017